Evan Goulding is a Psychiatry physician affiliated with Northwestern University. OpenAlex indexes 37 publications with 3,115 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
446 E Ontario St Ste 7-100
Chicago, IL 606114418
Telephone
312-695-5060Registry record last updated 18 Jan 2012.
Clinical trials
- LiveWell: A Mobile Intervention for Bipolar Disorder
Sponsor: Northwestern University
- A Mobile Behavioral Monitoring Intervention for Bipolar Disorder
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic19.5%Quetiapine Fumarate39%Aripiprazole18%Risperidone17%Olanzapine11%Vraylar10%Clozapine6%Part D<11 patientsSSRI15.9%Trazodone Hcl38%Escitalopram Oxalate23%Sertraline Hcl20%Fluoxetine Hcl19%Part D<11 patients+ 9 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2013–2023 per NIH RePORTER. The latest:
- Post-Graduate Research Training Aligned with the NIMH Strategic Plan
Northwestern University at Chicago
FY2023$196,899R25MH115855 - Post-Graduate Research Training Aligned with the NIMH Strategic Plan
Northwestern University at Chicago
FY2022$196,899R25MH115855 - Post-Graduate Research Training Aligned with the NIMH Strategic Plan
Northwestern University at Chicago
FY2021$196,899R25MH115855
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”